293.46
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CI?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Cigna Group Aktie (CI) Neueste Nachrichten
Cigna Group stock holds steady on its business mix - ad-hoc-news.de
Built with America: The Cigna Group’s 230-year history of innovation in service of customers - The Cigna Group Newsroom
Cigna Group (NYSE: CI) officer Bryan Holgerson details stock, 401(k) and option positions in Form 3 - Stock Titan
Cigna Group (NYSE: CI) officer Adam Kautzner details stock and option holdings - Stock Titan
Cigna Group (NYSE: CI) officer Jason Sadler reports share and option holdings - Stock Titan
Cigna Group (CI) officer Sanford Paul A reports holding 4,073 common shares - Stock Titan
Cigna Group (NYSE: CI) officer Matthew Perlberg reports initial stock and option holdings - Stock Titan
CI Maintained by Bernstein -- Price Target Raised to $381 - GuruFocus
What to Expect From Cigna's Next Quarterly Earnings Report - Yahoo Finance
Bernstein Adjusts Price Target on Cigna Group to $381 From $371 - marketscreener.com
Bernstein raises Cigna stock price target to $381 on earnings outlook - Investing.com
Cigna Group stock outperforms competitors on strong trading day - MarketWatch
CIGNA (CI) PT Raised to $381 at Bernstein SocGen Group - StreetInsider
Independent Pharmacies Accuse Prime Therapeutics of Price-Fixing Scheme With Express Scripts - Benzinga
Lawmakers Target the Power of Health Insurance Giants - The New York Times
Did Cigna's (CI) US$100 Million AI Pharmacy Bet Just Rewire Its Specialty-Care Narrative? - simplywall.st
Hope House Accepts Cigna, Aetna & UMR for Scottsdale Rehab - The Malone Telegram
Hope House Integrates UMR, Cigna & Aetna Into Admissions - The Malone Telegram
Another Wave Of Double-Digit Obamacare Rate Hikes Coming For 2027 - Forbes
Cigna Group focuses on health benefits growth as investors watch the US managed-care sector - Ad-hoc-news.de
The Cigna Group Foundation Launches 2026 Grant Program to Support Veterans - AOL.com
Cigna’s SWOT analysis: stock navigates PBM transition challenges - Investing.com
Cigna’s SWOT analysis: stock navigates PBM transition challenges By Investing.com - Investing.com Canada
Cigna Group stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Josh Michelson Appointed Executive Vice President, Chief Strategy and Innovation Officer at The Cigna Group - hrtoday.in
Specialty Pharmacy Gets Even Hotter After Cigna Investment And Peak Rock’s Asembia Buy - Forbes
The Cigna Group sets July 30 earnings call, webcast and replay - Stock Titan
Cigna Group focuses on health benefits and steady operations - ad-hoc-news.de
Cigna Group (CI) Could Be 17% Undervalued On Its $100 Million Evernorth AI Push - simplywall.st
Cigna Group stock underperforms Monday when compared to competitors - MarketWatch
The Cigna Group highlights its health services model as investors track long-term growth potential - ad-hoc-news.de
Prime Therapeutics Accused of Deflating Pharmacy Pay Rates (1) - Bloomberg Law News
UnitedHealth Bets on Profitability Over Growth: Will It Pay Off? - TradingView
Cigna slips as investors weigh PBM transition and a lack of fresh catalysts - Quiver Quantitative
Cigna Group outlines its role in US health coverage and benefits - ad-hoc-news.de
Cigna Group (CI) Stock Analysis: Unpacking an 18% Upside Potential Amidst Strong Buy Ratings - DirectorsTalk Interviews
Cigna (CI) Stock Just Lost Its Place In Key Russell Growth Indexes - Yahoo Finance
Cigna (CI) Stock Still Looks Cheap As Earnings Stay Strong - Yahoo Finance
Cigna (CI) Launches AI Pharmacy Program With $100 Million Behind It - simplywall.st
What Cigna Group (CI)'s US$100 Million Pharmacy Forward AI Bet Means For Shareholders - Yahoo Finance
The Cigna Group focuses on health services growth as investors watch its stock - ad-hoc-news.de
Cigna Brings AI to Specialty Pharmacy With Pharmacy Forward - Yahoo Finance Singapore
Goldman Sachs Maintains Cigna Group(CI.US) With Buy Rating, Maintains Target Price $340 - 富途牛牛
New Cigna CEO’s patient-first focus to face Wall Street test - Crain's New York
CICigna Group Volatility & Greeks - Finviz
Top Cigna Group (CI) Competitors 2026 - MarketBeat
Cigna's Evernorth division announces $100M specialty drug AI program - BenefitsPRO
Evernorth Invests $100M for AI Specialty Pharmacy Program - MedCity News
Evernorth Launches AI-Driven Specialty Care Initiative Backed by $100M Investment - citybiz
Cigna Group outlines growth strategy as health benefits demand evolves - AD HOC NEWS
Cigna (CI) Unveils $100M AI-Driven Specialty Care Program to Enh - GuruFocus
Cigna’s Evernorth Makes $100 Million AI Specialty Pharmacy Investment - Forbes
Cigna launches AI-enabled specialty care program with a $100M investment - Seeking Alpha
Cigna invests $100 million in new AI-powered specialty pharmacy program - Reuters
Cigna’s CEO vows to put patients first. Wall Street is watching - Modern Healthcare
New Cigna CEO’s Patient-First Focus to Face Wall Street Test - Bloomberg.com
New Cigna CEO’s Patient-First Focus to Face Wall Street Test (1) - Bloomberg Law News
Evernorth unveils new AI-powered specialty pharmacy program, Pharmacy Forward - Fierce Healthcare
The Evernorth Behavioral Health Program from Cigna Groupa quiet revenue engine in mental health c - AD HOC NEWS
AIDS Group Says Cigna-Owned Express Scripts Hurts Patients - Law360
Cigna, Others Fight Ohio AG's Drug Price-Fixing Suit - Law360
The Cigna Group (CI) Has a Health-Services Engine Bigger Than the Insurer Label - AlphaStreet
Cigna, UC Health extend contract as coverage negotiations continue - Sacramento Bee
Cigna Group stock underperforms Tuesday when compared to competitors - MarketWatch
Cigna and Community Medical Centers in contract dispute - ABC30 Fresno
Cigna Group outlines CEO transition as shares trade below recent highs - AD HOC NEWS
Cigna Group CEO transition and guidance lift, shares react ahead of July change - AD HOC NEWS
Cigna’s Removal From Russell Growth and Defensive Indices Might Change The Case For Investing In Cigna Group (CI) - simplywall.st
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):